Sandy Liebhard

Sandy A. Liebhard, a founding partner at Bernstein Liebhard LLP, has successfully represented plaintiffs in complex litigations for more than 20 years. As dedicated consumer advocates, Mr. Liebhard and his fellow attorneys have taken on some of the largest corporate interest in the nation in cases involving dangerous pharmaceuticals, faulty medical devices and defective consumer products. As an author for RXInuryHelp.com, Mr. Liebhard has written extensively on the litigation involving proton pump inhibitors (Nexium, Prilosec, PrevAcid, etc.) and kidney injuries; Risperdal and gynecomastia; the Bair Hugger forced air warming blanket; talcum powder and ovarian cancer; transvaginal mesh; power morcellators; defective hip implants; and more.

Mr. Liebhard is a 1988 graduate of Brooklyn Law School. He is admitted to the Bar of the State of New York, as well as the United States District Courts for the Southern and Eastern Districts of New York.


Talcum Powder Cancer Plaintiff Awarded $40.3 Million Verdict Against Johnson & Johnson

A California jury has ordered Johnson & Johnson to pay $40.3 million to a woman who developed mesothelioma following years of talcum powder use. Asbestos in Plaintiff]s Tissue After Cancer Diagnosis According to a talcum powder lawsuit filed in Los … Continue reading

1st Ethicon Physiomesh Lawsuit Trial Scheduled

The federal court overseeing thousands of hernia mesh lawsuits involving Ethicon, Inc.’s Physiomesh Flexible Composite mesh products has set a tentative date for the litigation’s first bellwether trial. Ethicon Physiomesh Bellwether Trials More than 2,360 Ethicon Physiomesh lawsuits are currently … Continue reading

CVS Latest Retailer to Pull Zantac-Like Drugs Over Cancer Worries

CVS Pharmacy has decided to remove all Zantac-like heart burn medications from store shelves across the country, amid growing concerns that the drugs are exposing consumers to a probable carcinogen. Valisure First to Raise Zantac Alarm Over-the-counter and prescription versions … Continue reading

Lymphoma Worries Prompt Textured Breast Implant Crackdown in Australia

Australian regulators are cracking down on textured breast implants, amid concerns that they may be causing some women to develop a rare form of cancer called anaplastic large cell lymphoma, or ALCL. 100 Breast Implant Lymphoma Cases Reported in Australia … Continue reading

Store-Brand Zantac Recalled from Walmart, Rite-Aid and Walgreens

Store brand versions of Zantac are being recalled from several retail chains, amid concerns that the products might contain unsafe levels of a cancer-causing chemical. What to Know About the Store-Brand Zantac Recall The drugs in question are manufactured by … Continue reading

Houston, Texas Hotels Hit with Sex Trafficking Lawsuit

Several hotels in Houston, Texas, have been implicated in sex trafficking, after a young woman filed a new lawsuit accusing the venues of enabling her exploitation. Sex Trafficking Lawsuit Allegations According to the sex trafficking lawsuit, the unidentified plaintiff was … Continue reading

GlaxoSmithKline Suspends Zantac Distribution, as Ranitidine Cancer Investigation Intensifies Worldwide

GlaxoSmithKline, the original manufacturer of Zantac, has suspended distribution of all ranitidine products, as health regulators around the world continue to investigate the presence of a cancer-causing chemical in the popular antacids. The company also announced it would be recalling … Continue reading

3M Combat Arms Earplugs Lawsuits Progress, With Approval of Master Complaint

The federal court overseeing thousands of lawsuits alleging permanent hearing loss and tinnitus caused by the 3M Company’s Combat Arms Earplugs has adopted a Master Complaint. Why a Master Complaint? About 2,200 cases involving Combat Arms Earplugs, Version 2, are … Continue reading

Novartis Announces First Generic Zantac Recall in Wake of NDMA Discovery

Novartis Is recalling generic Zantac medications marketed by its Sandoz, Inc. subsidiary, after determining the products contain N-Nitrosodimethylamine, or NDMA. Novartis is the first manufacturer to announce a Zantac recall since the U.S. Food & Drug Administration (FDA) warned that … Continue reading

Torrent Pharmaceuticals Announces Fifth Losartan Recall Expansion

Torrent Pharmaceuticals has expanded its losartan recall for a fifth time, after a potentially cancer-causing chemical turned up in more batches of the heart and blood pressure medication. The U.S. Food & Drug Administration (FDA) posted details of the recall … Continue reading

Follow Us

RXInjuryHelp.com on Google+  RXInjuryHelp.com on Facebook  RXInjuryHelp.com on LinkedIn  RXInjuryHelp.com on Twitter  RXInjuryHelp.com on YouTube  RXInjuryHelp.com on Pinterest

Skip to content